Univariate and multivariate Cox regression studies verified that high ARF6 expression was independently linked to raised death hazard in AML patients (multivariate HR = 1.634, 95% CI: 0.990–2.695, p = 0.045). Here, ARF6 is linked to acute myeloid leukemia.